Vanda Pharmaceuticals Inc.
DE ˙ DB ˙ US9216591084
5,26 € ↑0,09 (1,74%)
2026-06-05
DEL PRIS
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionRhumbline Advisers
Latest Disclosed Ownership71,328 shares
Latest Disclosed Value $ 492,864
Rhumbline Advisers reports 2.62% decrease in ownership of VM4 / Vanda Pharmaceuticals Inc.

On May 12, 2026 - Rhumbline Advisers filed a 13F-HR form disclosing ownership of 71,328 shares of Vanda Pharmaceuticals Inc. (DE:VM4) valued at $410,136 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 73,245 shares of Vanda Pharmaceuticals Inc.. This represents a change in shares of -2.62% during the quarter. The current value of the position is $375,185 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 71,328 -1,917 -2.62 493 -23.84 0.0004
2026-02-13 2025-12-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 73,245 -12,048 -14.13 646 52.00 0.0005
2025-11-06 2025-09-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 85,293 -1,253 -1.45 426 4.17 0.0003
2025-08-12 2025-06-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 86,546 647 0.75 408 3.55 0.0003
2025-05-29 2025-03-31 13F/A-1 VANDA PHARMACEUTICALS INC COM COM 921659108 85,899 -5,040 -5.54 394 -9.43 0.0004
2025-04-08 2025-03-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 85,899 -5,040 394 0.0004
2025-05-29 2024-12-31 13F/A-1 VANDA PHARMACEUTICALS INC COM COM 921659108 90,939 827 0.92 436 3.08 0.0004
2025-01-30 2024-12-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 90,939 827 436 0.0004
2024-11-12 2024-09-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 90,112 -9,442 -9.48 423 -24.91 0.0004
2024-08-01 2024-06-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 99,554 1,230 1.25 562 39.11 0.0005
2024-05-09 2024-03-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 98,324 -1,682 -1.68 404 -4.27 0.0004
2024-02-08 2023-12-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 100,006 -1,935 -1.90 422 -4.09 0.0004
2023-11-09 2023-09-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 101,941 -100,767 -49.71 440 -67.04 0.0005
2023-08-08 2023-06-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 202,708 9,100 4.70 1,336 133,400.00 0.0015
2023-05-11 2023-03-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 193,608 8,485 4.58 1 -99.93 0.0016
2023-02-14 2022-12-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 185,123 9,481 5.40 1,368 -21.15 0.0018
2022-11-10 2022-09-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 175,642 614 0.35 1,735 -9.07 0.0026
2022-08-11 2022-06-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 175,028 9,611 5.81 1,908 1.98 0.0028
2022-05-12 2022-03-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 165,417 -3,149 -1.87 1,871 -29.26 0.0024
2022-02-10 2021-12-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 168,566 -2,743 -1.60 2,645 -9.91 0.0032
2021-11-12 2021-09-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 171,309 -20,415 -10.65 2,936 -28.81 0.0040
2021-08-05 2021-06-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 191,724 -9,147 -4.55 4,124 36.69 0.0054
2021-05-06 2021-03-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 200,871 -309 -0.15 3,017 14.11 0.0041
2021-02-10 2020-12-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 201,180 17,873 9.75 2,644 49.29 0.0036
2020-11-12 2020-09-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 183,307 -15,573 -7.83 1,771 -22.15 0.0028
2020-08-13 2020-06-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 198,880 23,350 13.30 2,275 25.14 0.0038
2020-05-06 2020-03-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 175,530 3,163 1.84 1,818 -35.74 0.0038
2020-02-05 2019-12-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 172,367 8,770 5.36 2,829 30.19 0.0047
2019-10-23 2019-09-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 163,597 4,995 3.15 2,173 -2.77 0.0040
2019-08-14 2019-06-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 158,602 8,653 5.77 2,235 -18.99 0.0042
2019-05-01 2019-03-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 149,949 832 0.56 2,759 -29.18 0.0053
2019-01-31 2018-12-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 149,117 12,196 8.91 3,896 24.00 0.0085
2018-11-07 2018-09-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 136,921 85,370 165.60 3,142 219.96 0.0061
2018-08-06 2018-06-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 51,551 9,365 22.20 982 38.12 0.0020
2018-05-02 2018-03-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 42,186 -1,010 -2.34 711 8.22 0.0015
2018-02-09 2017-12-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 43,196 -8,125 -15.83 657 -28.51 0.0013
2017-11-06 2017-09-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 51,321 600 1.18 919 11.12 0.0020
2017-08-02 2017-06-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 50,721 6,299 14.18 827 32.96 0.0019
2017-05-02 2017-03-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 44,422 1,550 3.62 622 -9.06 0.0015
2017-01-27 2016-12-31 13F VANDA PHARMACEUTICALS INC COM COM 921659108 42,872 3,188 8.03 684 3.64 0.0017
2016-11-08 2016-09-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 39,684 -4,750 -10.69 660 32.80 0.0018
2016-08-11 2016-06-30 13F VANDA PHARMACEUTICALS INC COM COM 921659108 44,434 -1,259 -2.76 497 30.10 0.0015
2016-05-02 2016-03-31 13F VANDA PHARMACEUTICALS INC COMM COM 921659108 45,693 1,285 2.89 382 -7.51 0.0012
2016-02-03 2015-12-31 13F VANDA PHARMACEUTICALS INC COMM COM 921659108 44,408 2,515 6.00 413 -12.68 0.0013
2015-11-04 2015-09-30 13F VANDA PHARMACEUTICALS INC COMM COM 921659108 41,893 283 0.68 473 -10.42 0.0016
2015-08-04 2015-06-30 13F VANDA PHARMACEUTICALS INC COMM COM 921659108 41,610 2,965 7.67 528 47.08 0.0017
2015-05-12 2015-03-31 13F VANDA PHARMACEUTICALS INC COMM COM 921659108 38,645 9,625 33.17 359 -13.70 0.0010
2015-02-06 2014-12-31 13F VANDA PHARMACEUTICALS INC COMM COM 921659108 29,020 -775 -2.60 416 34.63 0.0012
2014-11-12 2014-09-30 13F VANDA PHARMACEUTICALS INC COMM COM 921659108 29,795 0 0.00 309 -35.89 0.0009
2014-08-06 2014-06-30 13F VANDA PHARMACEUTICALS INC COMM COM 921659108 29,795 1,273 4.46 482 4.10 0.0014
2014-05-06 2014-03-31 13F VANDA PHARMACEUTICALS INC COMM COM 921659108 28,522 -1,280 -4.30 463 25.14 0.0014
2014-02-03 2013-12-31 13F VANDA PHARMACEUTICALS INC COMM COM 921659108 29,802 1,810 6.47 370 20.52 0.0011
2013-11-05 2013-09-30 13F VANDA PHARMACEUTICALS INC COMM COM 921659108 27,992 1,412 5.31 307 42.79 0.0010
2013-08-07 2013-06-30 13F VANDA PHARMACEUTICALS INC COMM COM 921659108 26,580 26,580 215 0.0007
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.